Chronic kidney disease is a progressive and irreversible loss of the kidney function. Besides physical and treatment complications for chronic kidney disease, kidney patients also suffer a number of psychological problems, among which depression and anxiety are very common. This all, not only makes chronic kidney patients', already difficult life, more difficult but also furthermore vulnerable and at risk for earlier death. This study aimed to measure the level of anxiety and depression of chronic kidney disease patients have been measured and compared with the scores of healthy participants. Since haemodialysis is the most common treatment method for CKD, 60 haemodialysis patients at Inegol hospital in Turkey and 60 people from a general healthy population (N=120) were conveniently chosen to participate in this study. Following the literature review indicating possible psychological outcomes of chronic kidney failure and haemodialysis, depression and anxiety level among CKD patients and healthy cohort group was measured. Depression and anxiety levels were investigated using the Beck Depression Inventory II and The State-Trait Anxiety Inventory were used (Turkish versions 
Hemodialysis, although generally provided at hemodialysis centers at hospitals it is also possible to get home dialysis but research indicates more positive outcomes of hemodialysis in hospitals (National Institute of Diabetes and Digestive and Kidney Diseases, 2016). Besides facing chronic physical health condition, although rarely timely and properly diagnosed, chronic kidney patients face several psychological problems such as anxiety and depression. Despite poor chances to diagnose psychological problems of CKD patients, depression is the most common psychological problem among CKD patients (Bossola et al., 2010) and it is found to be very much prevalent among CKD patients, affecting up to 20% of CKD patients even before the initiation of dialysis (Hedayati et al., 2009 ). At the same time, there is a bidirectional relationship between depression and chronic medical illnesses due to the health risk behaviors and changes in the brain caused by depression which, in turn, increases the risk for chronic medical illnesses (Katon, 2011) . Besides physical changes in chronic kidney patients (Goldberg, 2010) which might underlie the development of depression, other possible reasons for depression development among chronic illness patients are related to experiencing multiple pain (Dworkin et al.,1990) , and stress due the change of lifestyle (Prince et al., 2007) .
Additionally, expected and commonly occurring decrease in the overall quality of life of chronic kidney patients makes patients more prone to develop psychological problems such as depression and anxiety (Ottaviani et al., 2016). Chronic kidney patients report experiencing symptoms which match with the symptoms of major depression such as, anhedonia and feelings of sadness, helplessness, guilt, hopelessness, which are usually accompanied by changes in sleep, appetite, and libido (Finkelstein, 2016 ).
Furthermore, chronic kidney patients report experiencing high anxiety levels during hemodialysis treatment, because it enables and triggers their thinking about the long-term health condition, survival and early mortality, financial issues, job status and fear of losing a job and getting the treatment (Acar, 2007). Anxiety, as an emotional reaction which is primarily characterized by feelings of tension and physical changes, affects the cognitive process (Cates et al., 1996) . Physical symptoms of anxiety among CKD patients are shown in chest pain, sweating, breathlessness, palpitations with the strong cognitive component in a form of the fear of dying. Given the multiplicity of issues to worry about and strong apprehension feeling due to the dialysis process; being hooked to hemodialysis machine working as an artificial kidney, with an establishment vascular access on their arms, monitoring the dialysate, the fluid cleaning unwanted waste products from patient's blood and, abundance of medications like analgesic, antimicrobial, hypoglycemic, diuretic, antihypertensive, erythropoietin (Sari, 2016) and potential medical complications (Sousa, 2008) , chronic kidney patients face multiple physical strains and psychological challenges. Chronic kidney patients are usually very weak following hemodialysis treatment; depend on others to take them to and from hospitals or private clinics, thus requiring care and support during and after the treatment. This might be additional vulnerability chronic patients feel besides the illness itself, making them vulnerable and prone to develop depression and anxiety (Kocabaşoğlu, 2004) . With this study, we aim at investigating the level of depression and anxiety among chronic kidney patients and the healthy control group.
Methodology Sample
This study has been done on a sample of 120 participants, comprising two groups, experimental and control. The experimental group consisted of 60 chronic kidney patients on hemodialysis (27 females and 33 males) at Inegöl Hospital in Turkey, and the equivalent of 60 people in control group (from different parts of Inegöl city) as representatives of the general healthy population. All participants were over 50 years of age. The convenient sampling method was used for participants' selection with the diagnosis of chronic kidney disease diagnosis and no chronic kidney diagnosis as a primary selection.
Procedure
After contacting the administration of Inegöl Public Hospital and acquiring permission to contact hemodialysis patients, chronic kidney patients were approached. Following ethical consideration, researcher (Baha Kurulmaz)
found 60 CKD patients, explained study aims and objective (ensuring confidentiality) inquired their willingness to participate in the study, after what they all agreed. Given their health condition, the researcher chose to ask participants all questions, one by one, and circled their responses.
Participation was voluntary and all went well. After collecting the data from experimental group, researcher reached 60 people, older than 50 years of age (in order to match experimental group), explained study aim and asked them to participate in the study. After they agreed, researcher again (to follow the same procedure) asked participants all questions, one by one, and circled their responses. Collected data has been entered into SPSS 20,  which was used to analyze and evaluate data collected.
Research questions and hypothesis
This study aimed to investigate depression and anxiety levels among chronic kidney patients, experimental, and healthy control group. anxiety. Trait anxiety items include: "I worry too much over something that really doesn't matter" and "I am content; I am a steady person." All items are rated on a 4-point scale (e.g., from "Almost Never" to "Almost Always"). Higher scores indicate greater anxiety. Considering our participants' background we used Turkish versions of both inventories, translated, adopted and already used in similar studies in Turkey. BDI has been adapted to Turkish language by Hisli (1989) and STAI has been adapted to Turkish language by Öner ve Le Comte (1983).
Results
Given our research aim, investigating depression and anxiety levels, central tendency measures, namely mean scores were, whose differences were further tested using t-test. Table 2 : T-test scores on depression for equality of means, both groups In the independent t-test testing, two unrelated groups on the same continuum were compared. As we can see, 005 which is equal to 005 which means that the variances are at the limit of homogeneity, but in the sig.(2-tailed) the value is ,000, what indicates a statistically significant difference between two groups when anxiety levels were compared.
DISCUSSION
The aim of this study was to investigate depression and anxiety levels among chronic kidney patients. We used quasi-experimental research design whereby, from a total of 120 participants, we had 60 chronic kidney patients in the experimental group and 60 from general (no kidney failure diagnosis) in the control group. To measure depression Beck Depression Inventory and The State-Trait Anxiety Inventory were used to measure depression and anxiety levels. Since our aim was to investigate depression and anxiety levels among people with chronic kidney disease and no chronic kidney disease, which were the only selection criteria and no additional demographic information was inquired from participants.
Depression level in among chronic kidney patients and control group
As hypothesized, we found higher depression levels in the experimental group, among chronic kidney patients when compared to control group.
Results indicate depression mean scores of experimental group 18.5, and 12. 66 in control group. Results of t-test indicate p =, 000 which less than 0.05 indicating statistically significant difference in means results between the groups. We can here say that the average of the experimental group from BDI match the criteria of depression according to BDI scoring. Our results match similar previous research and studies which also showed higher depression rates among CKD.
Chronic illnesses are difficult to cope with. From the beginning to the end, were three times more likely to be depressed. Depression rate was two times more present among patients with hypertension, diabetes, coronary artery disease, and heart failure while the rate is three times higher among end-stage renal disease, chronic obstructive pulmonary disease and cerebrovascular disease patients (Egede, 2007) . Studies also indicate more depression among children suffering from chronic kidney disease. For example, Kogon et al., (2013) conducted a cross-sectional on 44 patients aged 9-18 years with chronic kidney disease and found 30% overall prevalence of depression, indicating that depression is a common issue even for children with chronic kidney disease. Based on the study, we might say that not only adults but also children might face depression due to chronic kidney disease and its outcomes. In addition, Lee (2013) has conducted a study with 208 pre-dialysis chronic kidney patients and found 27.6% anxiety prevalence among these patients.
Cukor and colleagues (2008) with their study show 45.7% of chronic kidney disease patients have met the criteria for anxiety disorder, with specific phobias of 26.6% as most prevalent one followed by 21% of panic disorder.
Besides, chronic kidney disease interferes with other bodily functions. problems, pointing to 70% of male patients having impotence issues and around 50% having marital problems. So, chronic kidney disease is also related to sexual problems marital problems, which additionally complicate already vulnerable physical and mental health of chronic kidney patients.
Although we did not investigate these variables, it is possible that they could have influenced study results.
Hence, in line with previous studies, the prevalence of anxiety is quite high among chronic kidney disease patients. Facing chronic illness diagnosis requires different coping skills. Poor or lack of effective coping strategies and skills might be anxiety provoking. Adaption to this new stressful situation is hard, not only for the patient but also his/her family members as well.
Disease outcomes like physical changes, itching, sleeping problems, and sexual problems cannot be controlled by the patients, which in turn might make patients anxious, lonely and hopeless. Feeling lonely and isolated pushes patients away from family members and friends, because patients might be feeling uncomfortable to talk about the illness and its outcomes in order to avoid worrying family members. Chronic illness diagnosis usually induces fear and anxiety due to the fear about the future, wondering what will happen and become of them. At the same time, some studies indicate about 57 % of depression cases showed evidence of comorbid anxiety, while only 28% of those with clinically significant anxiety had concurrent depression. So, comorbidity of mental health disorders is common for patients with chronic disease (Braam et al., (2014) .
Still, we ought to acknowledge the possibility of other factors contributing to anxiety development like genetics, gender, age, life quality, family and social support, which we did not include in our study, which might be having a role in our study results and should be included in the future study. Family support and lack of it plays a significant role in disease recovery and mental health problems prevention. Family members play a very important role and also should be included to help chronic kidney disease patients because the entire family is somehow influenced by the disease.
Conclusion
Depression and anxiety are the most common mental health disorders to be found among chronic kidney disease patients. Possible reasons for anxiety and depression development among chronic kidney disease patients lies partially in the disease itself, partially in treatment techniques commonly used to treat this condition and partially in disease's overall aftermath.
Given the prevalence of depression and anxiety disorders among chronic kidney disease patients hospital services should offer psychological support and help to patients suffering from chronic kidney disease as well as their family members and some sort of holistic service. Besides diminishing and treating chronic illness and relieve negative outcomes of disease and its treatment, a holistic approach could be very useful in helping patients and family members cope on individual and group level.
